how to choose between semaglutide and tirzepatide vs. Semaglutide: Which is Best for Weight Loss? 🚨 Trying to choose between

Emerging from stealth in April with $290 million in financing, Metsera is partnering with Amneal as the preferred supplier for MET-097Metseras investigational, long-acting GLP-1 injectablein the U.S

"Patients with RLS improved significantly more under treatment of pregabalin than under placebo," says Diego Garcia-Borreguero, M.D., director of the Sleep Research Institute in Madrid, Spain

Some medications are approved for diabetes , some for obesity , and some for both

Healthcare professionals and patients in the UK have a professional and civic responsibility to report suspected adverse drug reactions to the Medicines and Healthcare products Regulatory Agency (MHRA) through the Yellow Card scheme

According to NICE guidance (NG28), GLP-1 receptor agonists are typically considered for type 2 diabetes when metformin is contraindicated or not tolerated, or in combination with other treatments when specific HbA1c and BMI thresholds are met